Allopurinol 300 MG Oral Tablet — RxCUI 197320
RxNorm drug concept · Semantic clinical drug
RxCUI 197320
Semantic clinical drug · SCD
● Current RxNorm concept 106 FDA products
250 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197320
Official nameAllopurinol 300 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped106
Package NDCs mapped250
Reported Medicaid activity (SDUD)839,024 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Allopurinol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Gout is caused by too much uric acid building up in your blood, which then forms sharp crystals in your joints — causing those painful flares. Allopurinol works by blocking the enz...
- Why did my doctor prescribe allopurinol, and how does it actually help my gout?
- This is really common and it doesn't mean the medicine isn't working. When uric acid levels start to drop, it can shake loose uric acid crystals from your tissues, temporarily trig...
- I started allopurinol and I'm actually getting more gout attacks — should I stop taking it?
🕸️ Concept Web — How Allopurinol 300 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Allopurinol 300 MG Oral Tablet
RxCUI 197320 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Allopurinol
519IN
-
Allopurinol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zyloprim
203600BN
-
Zyloprim
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Allopurinol Oral Tablet
370547SCDF -
Allopurinol Oral Product
1154941SCDG -
Allopurinol Pill
1154942SCDG -
Allopurinol Oral Tablet [Zyloprim]
368113SBDF -
Zyloprim Oral Product
1186496SBDG -
Zyloprim Pill
1186497SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Allopurinol Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Allopurinol 300 MG
315311SCDC -
Allopurinol 300 MG Oral Tablet [Zyloprim]
213998SBD -
Allopurinol 300 MG [Zyloprim]
573842SBDC
-
Allopurinol 300 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Allopurinol 300 MG
SCDC · 315311 -
Allopurinol Oral Tablet
SCDF · 370547 -
Allopurinol Oral Product
SCDG · 1154941 -
Allopurinol Pill
SCDG · 1154942
Brand-Name Concepts
-
Allopurinol 300 MG Oral Tablet [Zyloprim]
SBD · 213998 -
Allopurinol 300 MG [Zyloprim]
SBDC · 573842 -
Allopurinol Oral Tablet [Zyloprim]
SBDF · 368113 -
Zyloprim Oral Product
SBDG · 1186496 -
Zyloprim Pill
SBDG · 1186497 -
Zyloprim
BN · 203600
📦 FDA Products & Package NDCs
106 products · 250 package NDCs
250 package NDCs map to RxCUI 197320 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68788-8713-01 | 100 TABLET in 1 BOTTLE (68788-8713-1) | Allopurinol | Preferred Pharmaceuticals Inc. | 2024-07-11 |
| 68788-8713-03 | 330 TABLET in 1 BOTTLE (68788-8713-3) | Allopurinol | Preferred Pharmaceuticals Inc. | 2024-07-11 |
| 68788-8713-09 | 90 TABLET in 1 BOTTLE (68788-8713-9) | Allopurinol | Preferred Pharmaceuticals Inc. | 2024-07-11 |
| 68788-8865-01 | 100 TABLET in 1 BOTTLE (68788-8865-1) | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 2025-04-23 |
| 68788-8865-03 | 30 TABLET in 1 BOTTLE (68788-8865-3) | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 2025-04-23 |
| 68788-8865-06 | 60 TABLET in 1 BOTTLE (68788-8865-6) | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 2025-04-23 |
| 68788-8865-09 | 90 TABLET in 1 BOTTLE (68788-8865-9) | ALLOPURINOL | Preferred Pharmaceuticals Inc. | 2025-04-23 |
| 70518-3704-00 | 30 TABLET in 1 BLISTER PACK (70518-3704-0) | Allopurinol | REMEDYREPACK INC. | 2023-04-07 |
| 70518-3704-01 | 100 TABLET in 1 BOTTLE, PLASTIC (70518-3704-1) | Allopurinol | REMEDYREPACK INC. | 2024-02-01 |
| 70518-3704-03 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-3704-3) | Allopurinol | REMEDYREPACK INC. | 2025-07-21 |
| 70518-4286-00 | 30 TABLET in 1 BLISTER PACK (70518-4286-0) | Allopurinol | REMEDYREPACK INC. | 2025-02-11 |
| 70518-4404-00 | 30 TABLET in 1 BLISTER PACK (70518-4404-0) | ALLOPURINOL | REMEDYREPACK INC. | 2025-07-26 |
| 70518-4404-01 | 100 TABLET in 1 BOTTLE, PLASTIC (70518-4404-1) | ALLOPURINOL | REMEDYREPACK INC. | 2026-02-05 |
| 70518-4556-00 | 100 TABLET in 1 BOTTLE, PLASTIC (70518-4556-0) | Allopurinol | REMEDYREPACK INC. | 2026-01-26 |
| 70710-1209-00 | 1000 TABLET in 1 BOTTLE (70710-1209-0) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2018-02-08 |
| 70710-1209-01 | 100 TABLET in 1 BOTTLE (70710-1209-1) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2018-02-08 |
| 70710-1210-00 | 1000 TABLET in 1 BOTTLE (70710-1210-0) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2018-02-08 |
| 70710-1210-01 | 100 TABLET in 1 BOTTLE (70710-1210-1) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2018-02-08 |
| 70710-1210-05 | 500 TABLET in 1 BOTTLE (70710-1210-5) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2018-02-08 |
| 70710-2009-00 | 1000 TABLET in 1 BOTTLE (70710-2009-0) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2025-06-17 |
| 70710-2009-09 | 90 TABLET in 1 BOTTLE (70710-2009-9) | Allopurinol | Zydus Pharmaceuticals (USA) Inc. | 2025-06-17 |
| 70771-1126-00 | 1000 TABLET in 1 BOTTLE (70771-1126-0) | Allopurinol | Zydus Lifesciences Limited | 2018-02-08 |
| 70771-1126-01 | 100 TABLET in 1 BOTTLE (70771-1126-1) | Allopurinol | Zydus Lifesciences Limited | 2018-02-08 |
| 70771-1127-00 | 1000 TABLET in 1 BOTTLE (70771-1127-0) | Allopurinol | Zydus Lifesciences Limited | 2018-02-08 |
| 70771-1127-01 | 100 TABLET in 1 BOTTLE (70771-1127-1) | Allopurinol | Zydus Lifesciences Limited | 2018-02-08 |
| 70771-1127-05 | 500 TABLET in 1 BOTTLE (70771-1127-5) | Allopurinol | Zydus Lifesciences Limited | 2018-02-08 |
| 70771-1907-00 | 1000 TABLET in 1 BOTTLE (70771-1907-0) | Allopurinol | Zydus Lifesciences Limited | 2025-06-17 |
| 70771-1907-09 | 90 TABLET in 1 BOTTLE (70771-1907-9) | Allopurinol | Zydus Lifesciences Limited | 2025-06-17 |
| 71205-0049-30 | 30 TABLET in 1 BOTTLE (71205-049-30) | Allopurinol | Proficient Rx LP | 2018-06-01 |
| 71205-0049-60 | 60 TABLET in 1 BOTTLE (71205-049-60) | Allopurinol | Proficient Rx LP | 2018-06-01 |
| 71205-0049-90 | 90 TABLET in 1 BOTTLE (71205-049-90) | Allopurinol | Proficient Rx LP | 2018-06-01 |
| 71205-0377-30 | 30 TABLET in 1 BOTTLE, PLASTIC (71205-377-30) | Allopurinol | Proficient Rx LP | 2019-12-26 |
| 71205-0377-60 | 60 TABLET in 1 BOTTLE, PLASTIC (71205-377-60) | Allopurinol | Proficient Rx LP | 2019-12-26 |
| 71205-0377-90 | 90 TABLET in 1 BOTTLE, PLASTIC (71205-377-90) | Allopurinol | Proficient Rx LP | 2019-12-26 |
| 71335-0112-01 | 30 TABLET in 1 BOTTLE (71335-0112-1) | Allopurinol | Bryant Ranch Prepack | 2018-04-13 |
| 71335-0112-02 | 60 TABLET in 1 BOTTLE (71335-0112-2) | Allopurinol | Bryant Ranch Prepack | 2018-05-16 |
| 71335-0112-03 | 100 TABLET in 1 BOTTLE (71335-0112-3) | Allopurinol | Bryant Ranch Prepack | 2018-09-18 |
| 71335-0112-04 | 90 TABLET in 1 BOTTLE (71335-0112-4) | Allopurinol | Bryant Ranch Prepack | 2018-04-18 |
| 71335-0112-05 | 20 TABLET in 1 BOTTLE (71335-0112-5) | Allopurinol | Bryant Ranch Prepack | 2021-12-27 |
| 71335-2332-01 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-2332-1) | Allopurinol | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2332-02 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-2332-2) | Allopurinol | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2332-03 | 100 TABLET in 1 BOTTLE, PLASTIC (71335-2332-3) | Allopurinol | Bryant Ranch Prepack | 2024-03-13 |
| 71335-2332-04 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-2332-4) | Allopurinol | Bryant Ranch Prepack | 2024-04-03 |
| 71335-2332-05 | 20 TABLET in 1 BOTTLE, PLASTIC (71335-2332-5) | Allopurinol | Bryant Ranch Prepack | 2024-04-03 |
| 71335-3082-01 | 30 TABLET in 1 BOTTLE (71335-3082-1) | ALLOPURINOL | Bryant Ranch Prepack | 2026-02-13 |
| 71335-3082-02 | 60 TABLET in 1 BOTTLE (71335-3082-2) | ALLOPURINOL | Bryant Ranch Prepack | 2026-02-13 |
| 71335-3082-03 | 100 TABLET in 1 BOTTLE (71335-3082-3) | ALLOPURINOL | Bryant Ranch Prepack | 2026-02-13 |
| 71335-3082-04 | 90 TABLET in 1 BOTTLE (71335-3082-4) | ALLOPURINOL | Bryant Ranch Prepack | 2026-02-13 |
| 71335-3082-05 | 20 TABLET in 1 BOTTLE (71335-3082-5) | ALLOPURINOL | Bryant Ranch Prepack | 2026-02-13 |
| 71335-9634-01 | 30 TABLET in 1 BOTTLE (71335-9634-1) | Allopurinol | Bryant Ranch Prepack | 2023-03-13 |
Observed labelers:
Bryant Ranch Prepack (34) ·
Preferred Pharmaceuticals Inc. (15) ·
A-S Medication Solutions (13) ·
Indoco Remedies Limited (12) ·
Proficient Rx LP (12) ·
Rising Pharma Holdings, Inc. (12)
· +34 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.